Planned sale of 1,356 DGII (NASDAQ: DGII) shares disclosed in Form 144

Rhea-AI Filing Summary

A security holder of DGII has filed a Form 144 notice to sell 1,356 shares of common stock on the NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of 62,165.07. The filing lists 37,611,160 shares of common stock outstanding.

The shares to be sold were acquired in 2025 through an employee stock purchase plan and restricted stock awards. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1356	62165.07	37611160	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2025	Employee Stock Purchase Plan	Issuer			109	12/31/2025	Cash
Common	09/30/2025	Employee Stock Purchase Plan	Issuer			206	09/30/2025	Cash
Common	11/26/2025	Restricted Stock	Issuer			1041	11/26/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DGII Form 144 filing disclose about planned share sales?

The Form 144 shows a DGII security holder plans to sell 1,356 common shares on NASDAQ. The filing reports an aggregate market value of 62,165.07 and notes these shares were acquired through an employee stock purchase plan and restricted stock awards during 2025.

How many DGII shares are outstanding according to this Form 144?

The Form 144 states that 37,611,160 DGII common shares are outstanding. This figure provides context for the planned sale of 1,356 shares, allowing investors to see the relative size of the proposed transaction compared with the issuer’s total common stock base.

When are the DGII shares covered by this Form 144 expected to be sold?

The filing lists an approximate sale date of 02/10/2026 for the 1,356 DGII common shares. The shares are to be sold on the NASDAQ through Morgan Stanley Smith Barney LLC, subject to Rule 144 conditions and normal market and execution considerations.

How were the DGII shares in this Form 144 acquired by the seller?

The shares were acquired in 2025 through an employee stock purchase plan and restricted stock. Specific entries show purchases on 09/30/2025 and 12/31/2025 via the plan for cash, and a restricted stock award on 11/26/2025 with no cash payment listed.

What representation does the DGII Form 144 filer make about company information?

The person for whose account the DGII securities are to be sold represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144-related certification language.